Abstract:Objective To investigate the therapeutic effect of placenta mesenchymal stem cells (PMSC) transplantation on inflammatory factors and cartilage destruction in rheumatoid arthritis rats. Methods Totally 32 SD rats were randomly divided into experimental group (RA rats receiving PMSC) (n = 8), control group (RA rats receiving fibroblast cells) (n = 8), model group (RA rats without any treatments) (n = 8), and normal group(normalrats without any treatments) (n = 8). Rats received intravenous injection of cells 12 h after modeling. All rats were sacrificed 3 weeks after intervention. ELISA and PT-PCR were performed for further analysis. Results Levels of TNF-α, IL-1β and IL-6 were elevated in model group and control group when compared with normal control group (P < 0.05) while rats in experimental group experienced significantly lower levels of TNF-α, IL-1β and IL-6 when compared with model group. Expression of TGF-β was dramatically increased in experimental group when compared with remaining groups (P < 0.05). Levels of MMP-1, MMP-3 and MMP-13 were upregulated in model group and control group when compared with normal control group (P < 0.05) while rats in experimental group experienced significantly lower levels of MMP-1, MMP-3 and MMP-13 when compared with model group (P < 0.05). Levels of synovial cadherin-11 were upregulated in model group and control group when compared with normal control group (P < 0.05), while rats in experimental group experienced significantly lower levels of synovial cadherin-11 when compared with model group (P < 0.05). Conclusions Placenta derived mesenchymal stem cells reduce joint inflammation and cartilage destruction through reduction of TNF-α, interleukin 1, interleukin 6, MMPs, and cadherin-11 as well as upregulation of TGF-β in rats with rheumatoid arthritis.